Cambridge Nutritional Sciences plc
(the 'Company' or 'CNS')
Grant of Options
CNS (AIM: CNSL), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, announces that on 21 August 2025 the Board granted share options (the "Options") over its ordinary shares of 4 pence each ("Ordinary Shares") to Ajay Patel, Chief Financial Officer and Executive Director of the Company.
Following this grant of Options, the Company has in issue options over 20,273,843 Ordinary Shares, representing approximately 8.5 per cent. of the Company's total issued share capital. This is a reduction from the year end figure due to over 6 million share options having lapsed in that time.
| Director |
Number of Options granted |
Exercise Price |
Total options held |
| |
|
|
|
Grant of Options
The Options are subject to time conditions (as set out below); good/bad leaver provisions; and to Ajay remaining a director of the Company on the date of the Options vesting.
Options are subject to time conditions as follows:
| Proportion of Options |
Normal earliest exercise date |
| 34 per cent. ("Tranche One") |
On the second anniversary of 21 August 2025 |
| 33 per cent. ("Tranche Two") |
On the third anniversary of 21 August 2025 |
| 33 per cent. ("Tranche Three") |
On the fourth anniversary of 21 August 2025 |
For further information, please contact:
| Cambridge Nutritional Sciences Plc James Cooper, Chief Executive Officer
|
investors@cnsplc.com |
| Cavendish Capital Markets Limited (Nomad and Broker) Geoff Nash / Edward Whiley (Corporate Finance) Nigel Birks / Harriet Ward (Sales and ECM) |
Tel: 020 7220 0500 |
About Cambridge Nutritional Sciences Plc
Cambridge Nutritional Sciences Plc (AIM: CNSL) is the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
| 1 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||
| a) |
Name |
Ajay Patel |
||||
| 2. |
Reason for the notification |
|||||
| a) |
Position/status |
Chief Financial Officer, Executive Director |
||||
| b) |
Initial notification/ |
Initial Notification |
||||
| 3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
| a) |
Name |
Cambridge Nutritional Sciences plc |
||||
| b) |
LEI |
2138007U9P4BTZTYIR92 |
||||
| 4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
| a) |
Description of the |
Options over Ordinary Shares of 4p each |
||||
| Identification code |
ISIN: GB00B1VCP282 |
|||||
| b) |
Nature of |
Grant of Options |
||||
| c) |
Price(s) and volume(s) |
|
||||
| d) |
Aggregated information - Aggregated volume - Price |
As above |
||||
| e) |
Date of the |
21 August 2025 |
||||
| f) |
Place of the transactions |
Outside a trading venue |
||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.